{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T12:46:09Z","timestamp":1782737169920,"version":"3.54.5"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:00:00Z","timestamp":1778630400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:00:00Z","timestamp":1778630400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82174254"],"award-info":[{"award-number":["82174254"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CURR MED SCI"],"published-print":{"date-parts":[[2026,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To investigate the mechanistic role of Sijunzi decoction (SJZD) in overcoming chemoresistance through the suppression of adaptive metabolic responses in non\u2013small cell lung cancer (NSCLC).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Chemical profiling of SJZD-derived components in systemic circulation was conducted using liquid chromatography\u2013tandem mass spectrometry (LC\u2012MS\/MS) in Sprague\u2013Dawley rats. Multiomics integration and network pharmacology were employed to identify convergent targets shared by the bioactive constituents of SJZD and genes associated with cisplatin resistance.\n                      <jats:italic>In vitro<\/jats:italic>\n                      functional assessments using cisplatin-resistant human lung adenocarcinoma (A549\/DDP) cells included the following: quantification of cell viability via Cell Counting Kit-8 (CCK-8) assays; evaluation of mitochondrial bioenergetics through targeted metabolomic profiling; and ultrastructural characterization of ferroptotic morphology via transmission electron microscopy (TEM). Cellular redox homeostasis was dynamically monitored using fluorescent probes, including a DCFH-DA probe for reactive oxygen species (ROS) and a C11-BODIPY\n                      <jats:sup>581\/591<\/jats:sup>\n                      probe for lipid peroxidation. siRNA-mediated gene silencing and immunohistochemical analysis were performed to elucidate the functional hierarchy of the p62\/Keap1\/nuclear factor erythroid 2-related factor 2 (Nrf2) antioxidant axis. Complementary\n                      <jats:italic>in vivo<\/jats:italic>\n                      validation was performed using BALB\/c nude mice bearing A549\/DDP xenografts, with longitudinal monitoring of tumor progression under SJZD treatment regimens.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Untargeted metabolomics of SJZD-medicated serum revealed 392 differentially abundant metabolites, with pathway enrichment revealing significant dysregulation of glutamine metabolism. Structural validation confirmed 55 bioactive components of SJZD in serum, including glycyrrhizin, ginsenoside Ro, liquiritigenin, and atractylenolide I. Integration of these components with disease targets yielded 355 overlapping genes associated with both SJZD activity and cisplatin-resistant NSCLC, with significant enrichment in oxidative stress response pathways. Experimental assays confirmed that SJZD induced ferroptosis in cisplatin-resistant A549\/DDP cells, as evidenced by disrupted iron homeostasis, lipid peroxidation, and characteristic mitochondrial damage. These effects and subsequent cell death were specifically abrogated by the ferroptosis inhibitor ferrostatin-1 (Fer-1) but not by apoptosis inhibition, confirming that ferroptosis is the primary mechanism of cell death. Mechanistically, the inhibition of p62\/Keap1\/Nrf2 signaling was involved in the modulation of SJZD-induced ferroptosis both\n                      <jats:italic>in vitro<\/jats:italic>\n                      and\n                      <jats:italic>in vivo<\/jats:italic>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>SJZD counteracts metabolic adaptation through ferroptosis mediated by the inhibition of p62\/Keap1\/Nrf2 in cisplatin-resistant NSCLC.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11596-026-00203-x","type":"journal-article","created":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T06:15:55Z","timestamp":1778652955000},"page":"739-759","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Sijunzi Decoction Reverses Metabolic Adaptation and Induces Ferroptosis in Cisplatin-Resistant Non\u2013small Cell Lung Cancer: An Integrative Metabolomics\u2013Pharmacology Analysis"],"prefix":"10.1007","volume":"46","author":[{"given":"Wen-jun","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han-yu","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-ying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,13]]},"reference":[{"issue":"3","key":"203_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u2013249.","journal-title":"CA Cancer J Clin."},{"issue":"5","key":"203_CR2","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1016\/j.jhep.2025.04.034","volume":"83","author":"I Olaizola","year":"2025","unstructured":"Olaizola I, Odriozola-Gimeno M, Olaizola P, et al. New platinum derivatives selectively cause double-strand DNA breaks and death in na\u00efve and cisplatin-resistant cholangiocarcinomas. J Hepatol. 2025;83(5):1077\u20131091.","journal-title":"J Hepatol."},{"issue":"14","key":"203_CR3","doi-asserted-by":"publisher","first-page":"7379","DOI":"10.3390\/ijms22147379","volume":"22","author":"M Wangpaichitr","year":"2021","unstructured":"Wangpaichitr M, Theodoropoulos G, Nguyen DJM, et al. Cisplatin resistance and redox metabolic vulnerability: A second alteration. Int J Mol Sci. 2021;22(14):7379.","journal-title":"Int J Mol Sci."},{"issue":"2","key":"203_CR4","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/s41580-019-0173-8","volume":"21","author":"FJ Bock","year":"2020","unstructured":"Bock FJ, Tait SWG. Mitochondria as multifaceted regulators of cell death. Nat Rev Mol Cell Biol. 2020;21(2):85\u2013100.","journal-title":"Nat Rev Mol Cell Biol."},{"issue":"3","key":"203_CR5","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.cmet.2022.01.007","volume":"34","author":"NN Pavlova","year":"2022","unstructured":"Pavlova NN, Zhu J, Thompson CB. The hallmarks of cancer metabolism: Still emerging. Cell Metab. 2022;34(3):355\u2013377.","journal-title":"Cell Metab."},{"issue":"10","key":"203_CR6","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1038\/ncb3410","volume":"18","author":"M Pan","year":"2016","unstructured":"Pan M, Reid MA, Lowman XH, et al. Regional glutamine deficiency in tumours promotes dedifferentiation through inhibition of histone demethylation. Nat Cell Biol. 2016;18(10):1090\u20131101.","journal-title":"Nat Cell Biol."},{"issue":"1","key":"203_CR7","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.trecan.2019.11.009","volume":"6","author":"S McGuirk","year":"2020","unstructured":"McGuirk S, Audet-Delage Y, St-Pierre J. Metabolic fitness and plasticity in cancer progression. Trends Cancer. 2020;6(1):49\u201361.","journal-title":"Trends Cancer."},{"issue":"14","key":"203_CR8","doi-asserted-by":"publisher","DOI":"10.15252\/embj.201798597","volume":"37","author":"F Obrist","year":"2018","unstructured":"Obrist F, Michels J, Durand S, et al. Metabolic vulnerability of cisplatin\u2010resistant cancers. EMBO J. 2018;37(14):e98597.","journal-title":"EMBO J."},{"issue":"3","key":"203_CR9","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.cmet.2019.08.013","volume":"30","author":"J Kim","year":"2019","unstructured":"Kim J, DeBerardinis RJ. Mechanisms and implications of metabolic heterogeneity in cancer. Cell Metab. 2019;30(3):434\u2013446.","journal-title":"Cell Metab."},{"key":"203_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.794735","volume":"11","author":"WJ Liu","year":"2022","unstructured":"Liu WJ, Pan PY, Sun Y, et al. Deferoxamine counteracts cisplatin resistance in A549 lung adenocarcinoma cells by increasing vulnerability to glutamine deprivation-induced cell death. Front Oncol. 2022;11:794735.","journal-title":"Front Oncol."},{"issue":"1","key":"203_CR11","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1186\/s12943-024-02088-7","volume":"23","author":"H Wang","year":"2024","unstructured":"Wang H, Fleishman JS, Cheng S, et al. Epigenetic modification of ferroptosis by non-coding RNAs in cancer drug resistance. Mol Cancer. 2024;23(1):177.","journal-title":"Mol Cancer."},{"issue":"1","key":"203_CR12","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1038\/s41392-023-01720-0","volume":"8","author":"Y Wang","year":"2023","unstructured":"Wang Y, Hu J, Wu S, et al. Targeting epigenetic and posttranslational modifications regulating ferroptosis for the treatment of diseases. Signal Transduct Target Ther. 2023;8(1):449.","journal-title":"Signal Transduct Target Ther."},{"key":"203_CR13","doi-asserted-by":"publisher","first-page":"1290183","DOI":"10.3389\/fphar.2024.1290183","volume":"15","author":"Y Wang","year":"2024","unstructured":"Wang Y, Hu J, Fleishman JS, et al. Inducing ferroptosis by traditional medicines: a novel approach to reverse chemoresistance in lung cancer. Front Pharmacol. 2024;15:1290183.","journal-title":"Front Pharmacol."},{"issue":"5","key":"203_CR14","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","volume":"149","author":"SJ Dixon","year":"2012","unstructured":"Dixon SJ, Lemberg KM, Lamprecht MR, et al. Ferroptosis: An iron-dependent form of nonapoptotic cell death. Cell. 2012;149(5):1060\u20131072.","journal-title":"Cell."},{"issue":"4","key":"203_CR15","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","volume":"22","author":"X Jiang","year":"2021","unstructured":"Jiang X, Stockwell BR, Conrad M. Ferroptosis: Mechanisms, biology and role in disease. Nat Rev Mol Cell Biol. 2021;22(4):266\u2013282.","journal-title":"Nat Rev Mol Cell Biol."},{"issue":"7860","key":"203_CR16","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1038\/s41586-021-03539-7","volume":"593","author":"C Mao","year":"2021","unstructured":"Mao C, Liu X, Zhang Y, et al. DHODH-mediated ferroptosis defence is a targetable vulnerability in cancer. Nature. 2021;593(7860):586\u2013590.","journal-title":"Nature."},{"key":"203_CR17","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.2147\/DDDT.S506702","volume":"19","author":"X Li","year":"2025","unstructured":"Li X, Zhao L, Wang J, et al. The Mechanism of Sijunzi Decoction Suppresses Gastric Cancer Metastasis via the m6A Methyltransferase METTL14 Based on Untargeted Metabolomics Studies and Network Pharmacology Analysis. Drug Des Devel Ther. 2025;19:2369\u20132392.","journal-title":"Drug Des Devel Ther."},{"issue":"Pt A","key":"203_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2022.115876","volume":"302","author":"L Shang","year":"2023","unstructured":"Shang L, Wang Y, Li J, et al. Mechanism of Sijunzi Decoction in the treatment of colorectal cancer based on network pharmacology and experimental validation. J Ethnopharmacol. 2023;302(Pt A):115876.","journal-title":"J Ethnopharmacol."},{"key":"203_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2024.118115","volume":"329","author":"X Wang","year":"2024","unstructured":"Wang X, Pan S, Chen L, et al. Sijunzi decoction enhances sensitivity of colon cancer cells to NK cell destruction by modulating P53 expression. J Ethnopharmacol. 2024;329:118115.","journal-title":"J Ethnopharmacol."},{"issue":"2","key":"203_CR20","doi-asserted-by":"publisher","first-page":"27","DOI":"10.4103\/0976-0105.177703","volume":"7","author":"AB Nair","year":"2016","unstructured":"Nair AB, Jacob S. A simple practice guide for dose conversion between animals and human. J Basic Clin Pharm. 2016;7(2):27\u201331.","journal-title":"J Basic Clin Pharm."},{"key":"203_CR21","volume-title":"Pharmacopoeia of the People\u2019s Republic of China [S]","author":"Chinese Pharmacopoeia Commission","year":"2020","unstructured":"Chinese Pharmacopoeia Commission. Pharmacopoeia of the People\u2019s Republic of China [S]. 2020 Edition. Beijing: China Medical Science Press, 2020.","edition":"2020"},{"key":"203_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.653596","volume":"11","author":"Y Sun","year":"2021","unstructured":"Sun Y, Liu WJ, Zhao QY, et al. Down-Regulating the Expression of miRNA-21 Inhibits the Glucose Metabolism of A549\/DDP Cells and Promotes Cell Death Through the PI3K\/AKT\/mTOR\/HIF-1\u03b1 Pathway. Front Oncol. 2021;11:653596.","journal-title":"Front Oncol."},{"issue":"6","key":"203_CR23","first-page":"529","volume":"28","author":"RX Shang","year":"2018","unstructured":"Shang RX, Xu WD, Xu XQ, et al. Analysis of the major metabolites of Sijunzi decoction in rat serum based on HPLC-MS. J Jiangsu Univ (Medicine Edition), 2018;28(6):529\u2013533.","journal-title":"J Jiangsu Univ (Medicine Edition)"},{"key":"203_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115438","volume":"167","author":"ZH Wang","year":"2023","unstructured":"Wang ZH, Li TF, Li RS, et al. Sijunzi Tang improves gefitinib resistance by regulating glutamine metabolism. Biomed Pharmacother. 2023;167:115438.","journal-title":"Biomed Pharmacother."},{"issue":"19","key":"203_CR25","doi-asserted-by":"publisher","first-page":"3351","DOI":"10.1038\/s41388-020-01639-8","volume":"40","author":"J Eniafe","year":"2021","unstructured":"Eniafe J, Jiang S. The functional roles of TCA cycle metabolites in cancer. Oncogene. 2021;40(19):3351\u20133363.","journal-title":"Oncogene."},{"issue":"3","key":"203_CR26","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.cmet.2006.02.003","volume":"3","author":"WH Tong","year":"2006","unstructured":"Tong WH, Rouault TA. Functions of mitochondrial ISCU and cytosolic ISCU in mammalian iron-sulfur cluster biogenesis and iron homeostasis. Cell Metab. 2006;3(3):199\u2013210.","journal-title":"Cell Metab."},{"issue":"1","key":"203_CR27","doi-asserted-by":"publisher","first-page":"22","DOI":"10.4103\/jcrt.JCRT_862_16","volume":"17","author":"MD Jelic","year":"2021","unstructured":"Jelic MD, Mandic AD, Maricic SM, et al. Oxidative stress and its role in cancer. J Cancer Res Ther. 2021;17(1):22\u201328.","journal-title":"J Cancer Res Ther."},{"key":"203_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2021.725043","volume":"11","author":"FJ S\u00e1nchez-Garc\u00eda","year":"2021","unstructured":"S\u00e1nchez-Garc\u00eda FJ, P\u00e9rez-Hern\u00e1ndez CA, Rodr\u00edguez-Murillo M, et al. The Role of Tricarboxylic Acid Cycle Metabolites in Viral Infections. Front Cell Infect Microbiol. 2021;11:725043.","journal-title":"Front Cell Infect Microbiol."},{"key":"203_CR29","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.64611","volume":"10","author":"R Mainali","year":"2021","unstructured":"Mainali R, Zabalawi M, Long D, et al. Dichloroacetate reverses sepsis-induced hepatic metabolic dysfunction. Elife. 2021;10:e64611.","journal-title":"Elife."},{"key":"203_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2020.101483","volume":"32","author":"J Du","year":"2020","unstructured":"Du J, Zhou Y, Li Y, et al. Identification of Frataxin as a regulator of ferroptosis. Redox Biol. 2020;32:101483.","journal-title":"Redox Biol."},{"issue":"12","key":"203_CR31","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1038\/nrd4002","volume":"12","author":"C Gorrini","year":"2013","unstructured":"Gorrini C, Harris IS, Mak TW. Modulation of oxidative stress as an anticancer strategy. Nat Rev Drug Discovery. 2013;12(12):931\u2013947.","journal-title":"Nat Rev Drug Discovery."},{"issue":"4","key":"203_CR32","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1016\/j.cmet.2018.02.006","volume":"27","author":"SA Best","year":"2018","unstructured":"Best SA, De Souza DP, Kersbergen A, et al. Synergy between the KEAP1\/NRF2 and PI3K pathways drives non-small-cell lung cancer with an altered immune microenvironment. Cell Metab. 2018;27(4):935\u2013943.e934.","journal-title":"Cell Metab."},{"issue":"33","key":"203_CR33","doi-asserted-by":"publisher","first-page":"9671","DOI":"10.1021\/acs.jafc.1c03751","volume":"69","author":"Y Zhao","year":"2021","unstructured":"Zhao Y, Lu J, Mao A, et al. Autophagy inhibition plays a protective role in ferroptosis induced by alcohol via the p62\u2013Keap1\u2013Nrf2 pathway. J Agric Food Chem. 2021;69(33):9671\u20139683.","journal-title":"J Agric Food Chem."},{"issue":"10","key":"203_CR34","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0030420","volume":"3","author":"A Singh","year":"2006","unstructured":"Singh A, Misra V, Thimmulappa RK, et al. Dysfunctional KEAP1\u2013NRF2 interaction in non-small-cell lung cancer. PLoS Med. 2006;3(10):e420.","journal-title":"PLoS Med."},{"issue":"8","key":"203_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/oncsis.2017.65","volume":"6","author":"Z Fan","year":"2017","unstructured":"Fan Z, Wirth AK, Chen D, et al. Nrf2-Keap1 pathway promotes cell proliferation and diminishes ferroptosis. Oncogenesis. 2017;6(8):e371.","journal-title":"Oncogenesis."},{"issue":"1","key":"203_CR36","doi-asserted-by":"publisher","first-page":"4190","DOI":"10.1038\/s41467-019-12164-y","volume":"10","author":"SA Best","year":"2019","unstructured":"Best SA, Ding S, Kersbergen A, et al. Distinct initiating events underpin the immune and metabolic heterogeneity of KRAS-mutant lung adenocarcinoma. Nat Commun. 2019;10(1):4190.","journal-title":"Nat Commun."},{"issue":"11","key":"203_CR37","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1038\/nm.4407","volume":"23","author":"R Romero","year":"2017","unstructured":"Romero R, Sayin VI, Davidson SM, et al. Keap1 loss promotes Kras-driven lung cancer and results in dependence on glutaminolysis. Nat Med. 2017;23(11):1362\u20131368.","journal-title":"Nat Med."},{"issue":"1","key":"203_CR38","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.ccr.2012.05.016","volume":"22","author":"Y Mitsuishi","year":"2012","unstructured":"Mitsuishi Y, Taguchi K, Kawatani Y, et al. Nrf2 redirects glucose and glutamine into anabolic pathways in metabolic reprogramming. Cancer Cell. 2012;22(1):66\u201379.","journal-title":"Cancer Cell."},{"issue":"1","key":"203_CR39","doi-asserted-by":"publisher","first-page":"5043","DOI":"10.1038\/s41467-019-12925-9","volume":"10","author":"J Wang","year":"2019","unstructured":"Wang J, Lu Q, Cai J, et al. Nestin regulates cellular redox homeostasis in lung cancer through the Keap1\u2013Nrf2 feedback loop. Nat Commun. 2019;10(1):5043.","journal-title":"Nat Commun."},{"issue":"1","key":"203_CR40","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S0378-4274(02)00055-3","volume":"132","author":"R Tirumalai","year":"2002","unstructured":"Tirumalai R, Rajesh Kumar T, Mai KH, et al. Acrolein causes transcriptional induction of phase II genes by activation of Nrf2 in human lung type II epithelial (A549) cells. Toxicol Lett. 2002;132(1):27\u201336.","journal-title":"Toxicol Lett."},{"key":"203_CR41","doi-asserted-by":"crossref","unstructured":"Wang ZH. Study on the mechanism of Sijunzi Tang improving gefitinib resistance by regulating glutamine metabolism [Master\u2019s thesis]. Peking Union Medical College; 2022.","DOI":"10.1016\/j.biopha.2023.115438"},{"key":"203_CR42","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1016\/j.biopha.2018.12.026","volume":"111","author":"C Li","year":"2019","unstructured":"Li C, Niu M, Wang R, et al. The modulatory properties of Si Jun Zi Tang enhancing anticancer of gefitinib by an integrating approach. Biomed Pharmacother. 2019;111:1132\u20131140.","journal-title":"Biomed Pharmacother."},{"issue":"Pt A","key":"203_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2023.116948","volume":"318","author":"W Zhao","year":"2024","unstructured":"Zhao W, Liu Z, Zhang Z, et al. Si Jun Zi decoction inhibits the growth of lung cancer by reducing the expression of PD-L1 through TLR4\/MyD88\/NF-\u03baB pathway. J Ethnopharmacol. 2024;318(Pt A):116948.","journal-title":"J Ethnopharmacol."},{"issue":"4","key":"203_CR44","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1016\/j.freeradbiomed.2012.05.041","volume":"53","author":"L Zhan","year":"2012","unstructured":"Zhan L, Zhang H, Zhang Q, et al. Regulatory role of KEAP1 and NRF2 in PPAR\u03b3 expression and chemoresistance in human non-small-cell lung carcinoma cells. Free Radical Biol Med. 2012;53(4):758\u2013768.","journal-title":"Free Radical Biol Med."}],"container-title":["Current Medical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11596-026-00203-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11596-026-00203-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11596-026-00203-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T12:05:16Z","timestamp":1782734716000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11596-026-00203-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,13]]},"references-count":44,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["203"],"URL":"https:\/\/doi.org\/10.1007\/s11596-026-00203-x","relation":{},"ISSN":["2096-5230","2523-899X"],"issn-type":[{"value":"2096-5230","type":"print"},{"value":"2523-899X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,13]]},"assertion":[{"value":"15 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors declare that there are no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}},{"value":"This study was approved by Animal Care & Welfare Committee of Liaoning University of Traditional Chinese Medicine (Approval\u00a0No. 21000042021107). All procedures performed in the studies involving animals were in accordance with ARRIVE guidelines.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}}]}}